Abbott Diabetes And Cancer Milestones Contrast With Prolonged Share Price Weakness [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories (NYSE:ABT) secured European CE Mark approval for Libre Duo, described as the world's first dual glucose and ketone continuous monitoring sensor. The company presented new data at the American Diabetes Association's 2026 Scientific Sessions on diabetic ketoacidosis risk and outcomes from its Healthy Food Rx program for people with type 2 diabetes. The American Cancer Society reaffirmed Abbott's Cologuard and Cologuard Plus as preferred options in updated US colorectal cancer screening guidelines. Abbott Laboratories, trading at $89.17, is drawing fresh attention as these diabetes and cancer screening updates coincide with a mixed share performance record. The stock is up 2.5% over the past week and 8.0% over the past month, while it is down 28.2% year to date and down 32.7% over the past year. Over longer periods, the stock is down 8.3% over three years and down 11.0% over five years. For investors tracking NYSE:ABT, these developments highlight how Abbott
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap? [Yahoo! Finance]Yahoo! Finance
- Abbott Labs Vs. Danaher: Abbott's Everyday Products Beat Danaher's Slumping Biotech Equipment [Yahoo! Finance]Yahoo! Finance
- Probe of Alibaba unearthed evidence it knowingly let dangerous drugs be sold to U.S. consumers — but DOJ did not prosecute [CBS News]CBS News
- Schiff launches inquiry into DOJ's closure of probe into Abbott Labs over bacterial contamination at baby formula plant [CBS News]CBS News
- Detailed Hepatitis Testing Market Report Published, Segments Include Reagents, Kits, PCR, ELISA, and More [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 7/1/26 - Form 4
- 7/1/26 - Form 4
- 7/1/26 - Form 4
- ABT's page on the SEC website